Obesity Science & Practice (Dec 2023)

Association of body mass index with the development of metabolic acidosis in patients with chronic kidney disease

  • Vandana Mathur,
  • Nancy L. Reaven,
  • Susan E. Funk,
  • Thomas W. Ferguson,
  • Navdeep Tangri

DOI
https://doi.org/10.1002/osp4.672
Journal volume & issue
Vol. 9, no. 6
pp. 609 – 617

Abstract

Read online

Abstract Aims Higher body mass index (BMI) is associated with higher bone mass and bone serves as a buffer during the development of metabolic acidosis. The authors sought to examine the relationship between BMI and metabolic acidosis in patients with chronic kidney disease (CKD). Materials and Methods The study utilized a large US longitudinal data repository including over 103 million patients from healthcare provider organizations to evaluate the relationship between the exposure variable (BMI) and the prevalence and incidence of metabolic acidosis among patients with estimated glomerular filtration rate <60 ml/min/1.73 m2. Incident metabolic acidosis was identified at the first of two consecutive post‐index serum bicarbonate values, 10–365 days apart, between 12 and <22 mEq/L in patients with normal index serum bicarbonate. Cox proportional hazard models were adjusted for multiple variables including demographics, comorbidities, income, education, and kidney function. Results 103,766 patients qualified for this study; 6472 (6.2%) had metabolic acidosis at index. An inverse association between BMI category and metabolic acidosis was observed for both baseline (prevalence) and new‐onset (incidence) metabolic acidosis. Compared to BMI category of 18.5 to <25 kg/m2, each category of incrementally higher BMI was associated with a decreasing risk of incident metabolic acidosis; the adjusted hazard ratios (95% confidence interval) were 0.866 (0.824–0.911), 0.770 (0.729–0.813), 0.664 (0.622–0.709), and 0.612 (0.571–0.655) for BMI 25 to <30, 30 to <35, 35 to <40, and 40+ kg/m2, respectively. Conclusions Among patients with CKD, an incremental increase in BMI was inversely associated with both the prevalence and incidence of metabolic acidosis. These associations suggest that increased body weight may protect against the development of metabolic acidosis, a risk factor for progressive loss of kidney function.

Keywords